These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 10205265)

  • 41. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
    Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene.
    Niba ETE; Nishio H; Wijaya YOS; Lai PS; Tozawa T; Chiyonobu T; Yamadera M; Okamoto K; Awano H; Takeshima Y; Saito T; Shinohara M
    Brain Dev; 2021 Feb; 43(2):294-302. PubMed ID: 33036822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2.
    Prior TW; Swoboda KJ; Scott HD; Hejmanowski AQ
    Am J Med Genet A; 2004 Oct; 130A(3):307-10. PubMed ID: 15378550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A single strand conformation polymorphism-based carrier test for spinal muscular atrophy.
    Semprini S; Tacconelli A; Capon F; Brancati F; Dallapiccola B; Novelli G
    Genet Test; 2001; 5(1):33-7. PubMed ID: 11336398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA).
    Jedrzejowska M; Wiszniewski W; Zimowski J; Kostera-Pruszczyk A; Ryniewicz B; Bal J; Zaremba J; Mazurczak T; Hausmanowa-Petrusewicz I
    Neurol Neurochir Pol; 2005; 39(2):89-94. PubMed ID: 15871052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
    Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
    Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization.
    Le TT; Coovert DD; Monani UR; Morris GE; Burghes AH
    Neurogenetics; 2000 Sep; 3(1):7-16. PubMed ID: 11085591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mutation analysis of SMN gene in a patient and his family with spinal muscular atrophy].
    Zeng J; Lin YH; Yan AZ; Cai MY; Ke LF; Lan FH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):139-43. PubMed ID: 19350502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heteroduplex formation in SMN gene dosage analysis.
    Ogino S; Leonard DG; Rennert H; Gao S; Wilson RB
    J Mol Diagn; 2001 Nov; 3(4):150-7. PubMed ID: 11687598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families.
    Tsai CH; Jong YJ; Hu CJ; Chen CM; Shih MC; Chang CP; Chang JG
    J Neurol Sci; 2001 Sep; 190(1-2):35-40. PubMed ID: 11574104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of novel SMN1 subtle mutations using an allelic-specific RT-PCR.
    Xu Y; Xiao B; Liu Y; Qu XX; Dai MY; Ying XM; Jiang WT; Zhang JM; Liu XQ; Chen YW; Ji X
    Neuromuscul Disord; 2020 Mar; 30(3):219-226. PubMed ID: 32169315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population screening and cascade testing for carriers of SMA.
    Smith M; Calabro V; Chong B; Gardiner N; Cowie S; du Sart D
    Eur J Hum Genet; 2007 Jul; 15(7):759-66. PubMed ID: 17392705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molecular basis of spinal muscular atrophy: th SMN gene].
    Tizzano E; Baiget M
    Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The molecular basis of spinal muscular atrophy (SMA) in South African black patients.
    Labrum R; Rodda J; Krause A
    Neuromuscul Disord; 2007 Oct; 17(9-10):684-92. PubMed ID: 17627822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spinal muscular atrophy: molecular genetics and diagnostics.
    Ogino S; Wilson RB
    Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of PCR bias caused by a single nucleotide polymorphism in SMN gene dosage analysis.
    Ogino S; Wilson RB
    J Mol Diagn; 2002 Nov; 4(4):185-90. PubMed ID: 12411585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1.
    Helmken C; Hofmann Y; Schoenen F; Oprea G; Raschke H; Rudnik-Schöneborn S; Zerres K; Wirth B
    Hum Genet; 2003 Dec; 114(1):11-21. PubMed ID: 14520560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing.
    Kubo Y; Nishio H; Saito K
    J Hum Genet; 2015 May; 60(5):233-9. PubMed ID: 25716911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients.
    Dastur RS; Gaitonde PS; Khadilkar SV; Udani VP; Nadkarni JJ
    Neurol India; 2006 Sep; 54(3):255-9. PubMed ID: 16936383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.